Trial Profile
A Phase 1, Randomized, Open, Controlled, Comparative Safety, Tolerability and Efficacy Study of TT-173 in Healthy Volunteers After Tooth Extraction
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs TT 173 (Primary)
- Indications Haemophilia; Von Willebrand disease
- Focus Adverse reactions
- Sponsors Thrombotargets Corporation
- 12 Jun 2014 New trial record